U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C23H27N3O
Molecular Weight 361.48
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRENOXDIAZINE

SMILES

C(CC1=NC(CC(C2=CC=CC=C2)C3=CC=CC=C3)=NO1)N4CCCCC4

InChI

InChIKey=PXZDWASDNFWKSD-UHFFFAOYSA-N
InChI=1S/C23H27N3O/c1-4-10-19(11-5-1)21(20-12-6-2-7-13-20)18-22-24-23(27-25-22)14-17-26-15-8-3-9-16-26/h1-2,4-7,10-13,21H,3,8-9,14-18H2

HIDE SMILES / InChI

Description

Prenoxdiazine under the brand name Libexin is used as an antitussive agent. It was shown, that the use of this drug for pregnant women with an unproductive cough could be beneficial.

Approval Year

Unknown
149,124

Targets

Primary TargetPharmacologyConditionPotency
phagocytosis
3
Activator
1,447

PubMed

Patents

20050002865
228
20070224187
4
20090317473
3

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Oral
ACTIVE MOIETY
Structure of PRENOXDIAZINE
SALT/SOLVATE (PARENT)
Structure of PRENOXDIAZINE HYDROCHLORIDE
SALT/SOLVATE (PARENT)
Structure of PRENOXDIAZINE HIBENZATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966